effects [qlco]
Low-Dose Treatment [resa]
Testosterone [horm, phsu, strd]
Lipid Metabolism [moft]
Clotting factors [aapp, bacs, phsu]
Ovarian [bpoc]
Morphology [qlco]
Women [popg]
Introduction [hlca]
Low dose [qnco]
Androgen [horm, phsu]
Women [popg]
Symptomatic [ftcn]
treatment [ftcn]
sexual dysfunction [dsyn]
Premenstrual syndrome [dsyn]
Little NOS [cgab, dsyn]
Known [qlco]
Long-term [tmco]
Safety [hcpp]
Androgen [horm, phsu]
Women [popg]
This [euka]
Study [mnob]
investigated [ftcn]
effects [qlco]
Low testosterone [fndg]
Dose [qnco]
Exogenous [spco]
Lipid Metabolism [moft]
Marker [clna]
Activation [acty]
Coagulation [ortf]
System [ftcn]
Ovarian [bpoc]
Morphology [qlco]
Women [popg]
Patients [podg]
twenty [orch, phsu]
Two [qnco]
Severe [qlco]
Premenstrual syndrome [dsyn]
Age-Years [tmco]
Mean [qnco]
SD [fndg]
treated [topp]
subcutaneous [spco]
Testosterone implant [clnd]
mg% [qnco]
Six monthly [tmco]
Two [qnco]
Mean [qnco]
Duration [tmco]
Compared [acty]
Age [orga]
matched [resa]
Age-Years [tmco]
Control [grup]
Patients [podg]
Severe [qlco]
Premenstrual syndrome [dsyn]
Not [ftcn]
Received [qlco]
Testosterone [horm, phsu, strd]
treatment [ftcn]
Women [popg]
Continued [idcn]
To [qlco]
Regular [qlco]
Menses [orgf]
measurements [ftcn]
Fasting [fndg]
Blood sample [bdsu]
Obtained [ftcn]
Measurement [ftcn]
Lipids [lipd]
Clotting factors [aapp, bacs, phsu]
Ovarian [bpoc]
Ultrasound examination [diap]
carried [acty]
Out [spco]
days [tmco]
Menstrual cycle [orgf]
months [tmco]
Testosterone implant [clnd]
Testosterone [horm, phsu, strd]
treated [topp]
Group [idcn]
Result [ftcn]
Mean [qnco]
Plasma [bdsu]
Testosterone [horm, phsu, strd]
nmol/L [qnco]
nmol/L [qnco]
treated [topp]
Control Groups [grup]
Testosterone [horm, phsu, strd]
treated [topp]
Group [idcn]
Apolipoprotein A-I [aapp, bacs]
treated [topp]
Control [grup]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
treated [topp]
Control [grup]
nmol/L [qnco]
P NOS [aapp, imft]
Decreased [qnco]
Addition [ftcn]
Very low density lipoprotein cholesterol [bacs, strd]
treated [topp]
Control [grup]
nmol/L [qnco]
P NOS [aapp, imft]
Increased [qnco]
Testosterone [horm, phsu, strd]
treated [topp]
Patients [podg]
Total Cholesterol [lbpr]
Serum [bdsu]
Triglyceride [bacs, lipd]
Low Density Lipoprotein Cholesterol [bacs, strd]
Apolipoprotein B [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Lecithin Cholesterol Acyltransferase [aapp, enzy]
Cholesteryl Ester Transfer Protein [aapp, bacs]
activity [dora]
Clotting factors [aapp, bacs, phsu]
Two [qnco]
Group [idcn]
included [ftcn]
Time, Prothrombin [lbpr]
Fibrinogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Protein S [aapp, bacs]
free [ftcn]
Tissue Plasminogen Activator [aapp, enzy, phsu]
Plasminogen activator inhibitor [aapp, bacs]
beta-Thromboglobulin [aapp, bacs]
Prothrombin [aapp, bacs, phsu]
fragment [ftcn]
Ultrasound [diap]
Show [inpr]
Normal [qlco]
Ovarian [bpoc]
Architecture [ocdi]
Evidence [ftcn]
Polycystic change [qlco]
Ovarian [bpoc]
Patients [podg]
Testosterone [horm, phsu, strd]
treated [topp]
Group [idcn]
experience [menp]
symptoms [ftcn]
Testosterone [horm, phsu, strd]
treatment [ftcn]
complaints [fndg]
Hirsutism [fndg]
Acne [dsyn]
Requested [ftcn]
Termination [inpr]
treatment [ftcn]
Conclusion [idcn]
Low dose [qnco]
Administration [ocac]
Women [popg]
Over [spco]
Two [qnco]
Not [ftcn]
Induce [ftcn]
Ovarian [bpoc]
Architecture [ocdi]
Small [qnco]
Atherogenesis [patf]
effects [qlco]
Parameters [fndg]
Lipid [lipd]
lipoprotein metabolism [moft]
Detected [fndg]
Marker [clna]
Activation [acty]
Clotting [ortf]
System [ftcn]
Actual [qlco]
Increase [ftcn]
Risk [qlco]
Thrombosis [patf]
Overall [inpr]
Study [mnob]
Reassuring [hlca]
Data [idcn]
Safety [hcpp]
Low-Dose Treatment [resa]
Androgen [horm, phsu]
Women [popg]
Exercise [dora]
Women [popg]
Exist [cnce]
familial [famg]
Predisposition [clna]
Lipid [lipd]
Abnormalities [cgab]
Small [qnco]
Found [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Ape [mamm]
Very low density lipoprotein cholesterol [bacs, strd]
